Your browser doesn't support javascript.
loading
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson, Eva Tiensuu; Knigge, Ulrich; Dam, Gitte; Federspiel, Birgitte; Grønbaek, Henning; Stålberg, Peter; Langer, Seppo W; Kjaer, Andreas; Arola, Johanna; Schalin-Jäntti, Camilla; Sundin, Anders; Welin, Staffan; Thiis-Evensen, Espen; Sorbye, Halfdan.
Afiliação
  • Janson ET; Department of Medical Sciences, Endocrine Oncology Uppsala University, Uppsala, Sweden.
  • Knigge U; Departments of Surgery C and Endocrinology PE, Faculty of Health Science, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
  • Dam G; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Federspiel B; Department of Pathology, Faculty of Health Science, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Grønbaek H; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Stålberg P; Department of Surgical Sciences, Endocrine Surgery, Uppsala University, Uppsala, Sweden.
  • Langer SW; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
  • Kjaer A; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Arola J; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet, Copenhagen, Denmark.
  • Schalin-Jäntti C; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Sundin A; Department of Pathology, HUSLAB, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland.
  • Welin S; Endocrinology, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Thiis-Evensen E; Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
  • Sorbye H; Department of Medical Sciences, Endocrine Oncology Uppsala University, Uppsala, Sweden.
Acta Oncol ; 60(7): 931-941, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33999752
ABSTRACT

BACKGROUND:

The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.

AIM:

These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gástricas / Tumores Neuroendócrinos / Neoplasias Gastrointestinais / Neoplasias Intestinais Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gástricas / Tumores Neuroendócrinos / Neoplasias Gastrointestinais / Neoplasias Intestinais Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article